Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Bacterial Infections and Mycoses

Free Subscription Articles published in PLoS Med Retrieve available abstracts of 20 articles: HTML format

Single Articles

July 2025
1. ADJOBIMEY M, Trajman A, Bastos ML, Valiquette C, et al
   Rapid molecular testing or chest X-ray or tuberculin skin testing for household contact assessment of tuberculosis infection: A cluster-randomized trial.
   PLoS Med. 2025;22:e1004666.
   PubMed     Abstract available
   
   
   June 2025
2. OSENA G, Kapoor G, Kalanxhi E, Ouassa T, et al
   Antimicrobial resistance in Africa: A retrospective analysis of data from 14 countries, 2016-2019.
   PLoS Med. 2025;22:e1004638.
   PubMed     Abstract available
   
   
   May 2025
3. HSIEH YL, Horsburgh CR Jr, Cohen T, Miller JW, et al
   Cost-effectiveness of screening with transcriptional signatures for incipient TB among U.S. migrants.
   PLoS Med. 2025;22:e1004603.
   PubMed     Abstract available
   
   
   February 2025
4. GENG L, Whittles LK, Dickens BL, Chio MTW, et al
   Potential public health impacts of gonorrhea vaccination programmes under declining incidences: A modeling study.
   PLoS Med. 2025;22:e1004521.
   PubMed     Abstract available
   
   
   January 2025
5. KIM S, Can MH, Agizew TB, Auld AF, et al
   Factors associated with tuberculosis treatment initiation among bacteriologically negative individuals evaluated for tuberculosis: An individual patient data meta-analysis.
   PLoS Med. 2025;22:e1004502.
   PubMed     Abstract available
   
   
   December 2024
6. KEOGH-BROWN MR, Sumner T, Sweeney S, Vassall A, et al
   Estimating the health and macroeconomic burdens of tuberculosis in India, 2021-2040: A fully integrated modelling study.
   PLoS Med. 2024;21:e1004491.
   PubMed     Abstract available
   
   
   November 2024
7. MACPHERSON P, Stagg HR, Schwalb A, Henderson H, et al
   Impact of active case finding for tuberculosis with mass chest X-ray screening in Glasgow, Scotland, 1950-1963: An epidemiological analysis of historical data.
   PLoS Med. 2024;21:e1004448.
   PubMed     Abstract available
   
   
   October 2024
8. DE JONG BC, Nourdine S, Bergeman AT, Salim Z, et al
   Safety of single-dose bedaquiline combined with rifampicin for leprosy post-exposure prophylaxis: A Phase 2 randomized non-inferiority trial in the Comoros Islands.
   PLoS Med. 2024;21:e1004453.
   PubMed     Abstract available
   
   
   September 2024
9. CALDERWOOD CJ, Marambire ET, Larsson L, Banze D, et al
   HIV, malnutrition, and noncommunicable disease epidemics among tuberculosis-affected households in east and southern Africa: A cross-sectional analysis of the ERASE-TB cohort.
   PLoS Med. 2024;21:e1004452.
   PubMed     Abstract available
   
   
   July 2024
10. BURMAN W, Rucsineanu O, Horsburgh CR, Johnston J, et al
    Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach.
    PLoS Med. 2024;21:e1004438.
    PubMed     Abstract available
    
    
    
11. YIN X, Li Y, Ronn MM, Li S, et al
    Assessing thresholds of resistance prevalence at which empiric treatment of gonorrhea should change among men who have sex with men in the US: A cost-effectiveness analysis.
    PLoS Med. 2024;21:e1004424.
    PubMed     Abstract available
    
    
    
12. LECLERC QJ, Duval A, Guillemot D, Opatowski L, et al
    Using contact network dynamics to implement efficient interventions against pathogen spread in hospital settings: A modelling study.
    PLoS Med. 2024;21:e1004433.
    PubMed     Abstract available
    
    
    June 2024
13. PEREZ CHACON G, Estcourt MJ, Totterdell J, Marsh JA, et al
    Immunogenicity, reactogenicity, and IgE-mediated immune responses of a mixed whole-cell and acellular pertussis vaccine schedule in Australian infants: A randomised, double-blind, noninferiority trial.
    PLoS Med. 2024;21:e1004414.
    PubMed     Abstract available
    
    
    
14. LEACH AJ, Wilson N, Arrowsmith B, Beissbarth J, et al
    Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules.
    PLoS Med. 2024;21:e1004375.
    PubMed     Abstract available
    
    
    May 2024
15. JHAVERI TA, Jhaveri D, Galivanche A, Lubeck-Schricker M, et al
    Barriers to engagement in the care cascade for tuberculosis disease in India: A systematic review of quantitative studies.
    PLoS Med. 2024;21:e1004409.
    PubMed     Abstract available
    
    
    
16. JAMES LP, Klaassen F, Sweeney S, Furin J, et al
    Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.
    PLoS Med. 2024;21:e1004401.
    PubMed     Abstract available
    
    
    
17. MICHALOW J, Walters MK, Edun O, Wybrant M, et al
    Aetiology of vaginal discharge, urethral discharge, and genital ulcer in sub-Saharan Africa: A systematic review and meta-regression.
    PLoS Med. 2024;21:e1004385.
    PubMed     Abstract available
    
    
    
18. OKEEFFE J, Salem-Bango L, Desjardins MR, Lantagne D, et al
    Case-area targeted interventions during a large-scale cholera epidemic: A prospective cohort study in Northeast Nigeria.
    PLoS Med. 2024;21:e1004404.
    PubMed     Abstract available
    
    
    April 2024
19. CHEN L, Xing Y, Zhang Y, Xie J, et al
    Long-term variations of urban-Rural disparities in infectious disease burden of over 8.44 million children, adolescents, and youth in China from 2013 to 2021: An observational study.
    PLoS Med. 2024;21:e1004374.
    PubMed     Abstract available
    
    
    March 2024
20. EMANI S, Alves K, Alves LC, da Silva DA, et al
    Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
    PLoS Med. 2024;21:e1004361.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bacterial Infections and Mycoses is free of charge.